|
|
|
42
|
4092K
|
GLYCEROL 2G SUPPOS (MTP) GLYCERINE
|
GLYCERINE
|
GLYCEROL
|
12'S
|
A
|
8.62
|
0.72
|
SUPP
|
12
|
BLIS
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5612
|
CATHARTICS AND LAXATIVES
|
2026-04-01
|
2028-03-31
|
|
RECTAL
|
0
|
CATHARTICS AND LAXATIVES
|
|
|
|
|
40
|
41011
|
ZOMETA 4MG INJ (NVS/COL) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOMETA
|
4MG VIAL
|
C
|
842.68
|
842.68
|
INJECTION
|
0
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
41011
|
ZOMETA 4MG INJ (NVS) ZOLENDRONIC ACID (C)
|
ZOLENDRONIC ACID
|
ZOMETA
|
4MG VIAL
|
C
|
706.76
|
706.7642
|
VIAL
|
2
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
42
|
41011
|
ZOMETA 4MG INJ (NVS) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOMETA
|
4MG VIAL
|
C
|
706.76
|
706.76
|
VIAL
|
2
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
IV
|
6
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
41
|
41016
|
ZOLENDRONIC ACID 4MG INJ (ZUV) (BQ)
|
ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
4MG VIAL
|
BQ
|
13.59
|
13.5916
|
VIAL
|
2
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
INJ
|
6
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
42
|
41016
|
ZOLENDRONIC ACID 4MG INJ (ZUV)
|
ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
4MG VIAL
|
BQ
|
8.54
|
8.54
|
VIAL
|
2
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
INJ
|
0
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
40
|
4101A
|
ZOLENDRONIC ACID 4MG INJ (SLS/AHI)
|
ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
4MG VIAL
|
BQ
|
38.95
|
38.95
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-03-29
|
|
|
|
41
|
4101A
|
ZOLENDRONIC ACID 4MG INJ (SLS) (BQ)
|
ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
4MG VIAL
|
BQ
|
30.42
|
30.418
|
VIAL
|
2
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2024-04-01
|
2024-05-27
|
|
IV
|
6
|
BONE RESORPTION INHIBITORS
|
2024-04-15
|
|
|
|
40
|
4101E
|
ZOLASTA 4MG INJ (INP/AHI) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOLASTA
|
5ML
|
BQ
|
35.07
|
35.07
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
4101Q
|
ZOLOSTEO 4MG INJ (JLP) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOLOSTEO
|
12X4MG
|
BQ
|
108.73
|
9.06
|
VIAL
|
2
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
40
|
4121B
|
METHYLPREDNISOLONE SODIUM SUCCINATE 500MG INJ (KWA/ATB)
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
500MG VIAL
|
B
|
15.36
|
15.36
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6804
|
ADRENALS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-03-30
|
|
|
|
41
|
4121B
|
METHYLPRED. SOD. SUCC. 500MG INJ (KWA) METHYLPREDNISOLONE SO (BQ)
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPRED. SOD. SUCC.
|
500MG VIAL
|
BQ
|
9.7
|
9.7044
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ADRENALS
|
|
|
|
|
40
|
4121D
|
METHYLPREDNISOLONE SODIUM SUCCINATE 500MG INJ (MON/PHA)
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
10ML VIAL
|
B
|
10.55
|
10.55
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
4121G
|
METHYLPRED. SOD. SUCC. 500MG INJ (FSB) METHYLPREDNISOLONE SO (BQ)
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPRED. SOD. SUCC.
|
500MG VIAL
|
BQ
|
9.43
|
9.4326
|
VIAL
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ADRENALS
|
|
|
|
|
42
|
4121J
|
METHYLPRED. SOD. SUCC. 50MG/ML INJ (BAX) METHYLPREDNISOLONE
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPRED. SOD. SUCC.
|
10X10ML
|
BQ
|
68.42
|
6.84
|
VIAL
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
6804
|
ADRENALS
|
2026-04-01
|
2028-03-31
|
|
IV/IM
|
0
|
ADRENALS
|
|
|
|
|
41
|
4141AF
|
NAPROXEN 500MG TAB (CPP)
|
NAPROXEN
|
NAPROXEN
|
28'S
|
A
|
4.19
|
0.1495
|
TAB
|
28
|
BOX
|
CPP
|
WOCKHARDT UK LTD
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4141DQ
|
APO-NAPROXEN 500MG TAB (APO)
|
NAPROXEN
|
APO-NAPROXEN
|
100'S
|
C
|
38.98
|
0.39
|
TAB
|
28
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
4141FX
|
PONSTAN FORTE 500MG TAB (PFI/STO) MEFENAMIC A
|
MEFENAMIC ACID
|
PONSTAN FORTE
|
50'S
|
C
|
15.14
|
0.30
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
4141FX
|
PONSTAN FORTE 500MG TAB (PFI) MEFEN (C)
|
MEFENAMIC ACID
|
PONSTAN FORTE
|
50'S
|
C
|
15.28
|
0.3055
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4141FX
|
PONSTAN FORTE 500MG TAB (PFI) MEFEN
|
MEFENAMIC ACID
|
PONSTAN FORTE
|
50'S
|
C
|
15.28
|
0.31
|
TAB
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|